Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 8 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 29,451 followers.

RT @JlMorell: Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patient…

22 Feb 2023

Reply Repost Favourite

Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patients with solid malignancies https://t.co/GYqrm0nQSl

20 Feb 2023

Reply Repost Favourite

RT @FrontOncology: New research: Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic synd…

27 Jan 2023

Reply Repost Favourite

Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies https://t.co/2HEnaEsQ8j https://t.co/zbQAVlXAIC

26 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.